MP:0001273 | decreased metastatic potential | |
Show
Allelic Composition: Apptm1.1Wevn/Apptm1.1Wevn Genetic Background: B6.129S6(FVB)-Apptm1.1Wevn
|
MP:0001861 | lung inflammation | "local accumulation of fluid, plasma proteins, and leukocytes in the lung" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: Apptm1.1Wevn/Apptm1.1Wevn Genetic Background: B6.129S6(FVB)-Apptm1.1Wevn
|
MP:0002497 | increased IgE | "greater than normal immunoglobulin class E level" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Apptm1.1Wevn/Apptm1.1Wevn Genetic Background: B6.129S6(FVB)-Apptm1.1Wevn
|
MP:0005011 | increased eosinophil count | "greater than normal eosinophil numbers" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Apptm1.1Wevn/Apptm1.1Wevn Genetic Background: B6.129S6(FVB)-Apptm1.1Wevn
|
MP:0005165 | increased susceptibility to injury | "greater than the normal reaction to trauma, especially that by physical means" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Apptm1.1Wevn/Apptm1.1Wevn Genetic Background: B6.129S6(FVB)-Apptm1.1Wevn
|
MP:0006050 | pulmonary fibrosis | "formation of fibrous tissue within the lung often resulting from inflammation or injury " [RGD:Rat Genome Database submission, smb:Susan M Bello, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Apptm1.1Wevn/Apptm1.1Wevn Genetic Background: B6.129S6(FVB)-Apptm1.1Wevn
|
MP:0008672 | increased interleukin-13 secretion | "increase in the production or release of a cytokine synthesized by T-cells that produces proliferation, immunoglobulin isotype switching, and immunoglobulin production by immature B-cells, and appears to play a role in regulating inflammatory and immune responses" [MESH:D12.644.276.374.465.513] |
Show
Allelic Composition: Apptm1.1Wevn/Apptm1.1Wevn Genetic Background: B6.129S6(FVB)-Apptm1.1Wevn
|
MP:0008699 | increased interleukin-4 secretion | "increase in the production or release of a soluble factor produced by activated T-cells that induces the expression of MHC class II genes and FC receptors on B-cells and causes their proliferation and differentiation; it also acts on T-cells, mast cells and several other hematopoietic lineage cells" [MESH:D12.644.276.374.465.504] |
Show
Allelic Composition: Apptm1.1Wevn/Apptm1.1Wevn Genetic Background: B6.129S6(FVB)-Apptm1.1Wevn
|
MP:0008837 | increased transforming growth factor level | "greater concentration of a paracrine growth factor that has a potential role in embryonic development, cellular differentiation, hormone secretion, and immune function" [MESH:D12.644.276.374.687] |
Show
Allelic Composition: Apptm1.1Wevn/Apptm1.1Wevn Genetic Background: B6.129S6(FVB)-Apptm1.1Wevn
|
MP:0008838 | decreased transforming growth factor level | "reduced concentration of a paracrine growth factor that has a potential role in embryonic development, cellular differentiation, hormone secretion, and immune function" [MESH:D12.644.276.374.687] |
Show
Allelic Composition: Apptm1.1Wevn/Apptm1.1Wevn Genetic Background: B6.129S6(FVB)-Apptm1.1Wevn
|
MP:0020344 | abnormal susceptibility to injury induced morbidity/mortality | "differences from the expected moribund state caused by trauma, especially that by physical means" [ORCID: orcid.org/0000-0003-4606-0597] |
Show
Allelic Composition: Apptm1.1Wevn/Apptm1.1Wevn Genetic Background: B6.129S6(FVB)-Apptm1.1Wevn
|
MP:0030002 | increased lung apoptosis | "acceleration in the timing or in the number of cells of the lung undergoing programmed cell death" [ORCID:orcid.org/0000-0002-6490-7723, PMID:17589521] |
Show
Allelic Composition: Apptm1.1Wevn/Apptm1.1Wevn Genetic Background: B6.129S6(FVB)-Apptm1.1Wevn
|